Report error Found 21 Enz. Inhib. hit(s) with all data for entry = 13541
TargetE3 ubiquitin-protein ligase CBL-B/Tyrosine-protein kinase Lck(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 100nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
TargetE3 ubiquitin-protein ligase CBL-B/Tyrosine-protein kinase Lck(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 100nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
TargetE3 ubiquitin-protein ligase CBL-B/Tyrosine-protein kinase Lck(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 100nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
TargetE3 ubiquitin-protein ligase CBL-B/Tyrosine-protein kinase Lck(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 100nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
TargetE3 ubiquitin-protein ligase CBL-B/Tyrosine-protein kinase Lck(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 100nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
TargetE3 ubiquitin-protein ligase CBL-B/Tyrosine-protein kinase Lck(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 100nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
TargetE3 ubiquitin-protein ligase CBL-B/Tyrosine-protein kinase Lck(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 100nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
TargetE3 ubiquitin-protein ligase CBL-B/Tyrosine-protein kinase Lck(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 100nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
TargetE3 ubiquitin-protein ligase CBL-B/Tyrosine-protein kinase Lck(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 100nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
TargetE3 ubiquitin-protein ligase CBL-B/Tyrosine-protein kinase Lck(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 300nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
TargetE3 ubiquitin-protein ligase CBL-B/Tyrosine-protein kinase Lck(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 300nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
TargetE3 ubiquitin-protein ligase CBL-B/Tyrosine-protein kinase Lck(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 300nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
TargetE3 ubiquitin-protein ligase CBL-B/Tyrosine-protein kinase Lck(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 300nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
TargetE3 ubiquitin-protein ligase CBL-B/Tyrosine-protein kinase Lck(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 300nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
TargetE3 ubiquitin-protein ligase CBL-B/Tyrosine-protein kinase Lck(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 300nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
TargetE3 ubiquitin-protein ligase CBL-B/Tyrosine-protein kinase Lck(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 300nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
TargetE3 ubiquitin-protein ligase CBL-B/Tyrosine-protein kinase Lck(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 300nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
TargetE3 ubiquitin-protein ligase CBL-B/Tyrosine-protein kinase Lck(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 5.25E+3nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
TargetE3 ubiquitin-protein ligase CBL-B/Tyrosine-protein kinase Lck(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 5.25E+3nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
TargetE3 ubiquitin-protein ligase CBL-B/Tyrosine-protein kinase Lck(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 5.25E+3nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
TargetE3 ubiquitin-protein ligase CBL-B/Tyrosine-protein kinase Lck(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 5.25E+3nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair




















